Effectiveness of Mindfulness-Based Cognitive Therapy on Depressive Symptoms, Brain Potential, and Neuroimmunoinflammatory Factors in Depressed Patients
Related Experiment Video
Updated: Jun 21, 2025

Combining Behavior and EEG to Study the Effects of Mindfulness Meditation on Episodic Memory
Published on: May 11, 2020
Jiancheng Qiu1, Yifei Gong2, Xiucui Zhang2
1From the Department of Psychiatry, Nantong Fourth People's Hospital, Nantong, Jiangsu Province, China.
Insights
Mindfulness-based cognitive therapy (MBCT) significantly reduces depressive symptoms and inflammation. This therapy also improves attention and response times in patients with depression, making it a valuable clinical option.
Area of Science:
- Clinical Psychology
- Neuroscience
- Psychiatry
Background:
- Depression is a prevalent mental health disorder associated with significant disability.
- Neuroimmunoinflammatory pathways and altered brain potentials are implicated in the pathophysiology of depression.
- Existing treatments for depression have limitations, necessitating exploration of novel therapeutic approaches.
Purpose of the Study:
- To evaluate the efficacy of mindfulness-based cognitive therapy (MBCT) in treating depressive symptoms.
- To assess the impact of MBCT on specific brain potentials and neuroimmunoinflammatory markers in depressed patients.
- To compare the effects of MBCT combined with conventional therapy against conventional therapy alone.
Main Methods:
- A randomized controlled trial involving 64 patients diagnosed with depression.
- Participants were assigned to either a control group (conventional therapy) or an observation group (MBCT plus conventional therapy).
- Measurements included depressive symptom scales (Hamilton Depression Rating Scale), quality of life (WHOQOL-BREF), cognitive function (response execution), neurotransmitter levels (5-HT), inflammatory markers (TNF-α, IL-6), and brain potentials (latency, amplitude).
Main Results:
- Both groups showed improvements in depressive symptoms, quality of life, response execution, 5-HT levels, and inflammatory markers.
- The MBCT group exhibited significantly greater reductions in depressive symptoms, TNF-α, and IL-6 levels compared to the control group.
- The MBCT group also demonstrated significantly greater improvements in quality of life, response execution, 5-HT levels, and altered brain potential characteristics (shorter latency, longer amplitude).
Conclusions:
- Mindfulness-based cognitive therapy (MBCT), when added to conventional therapy, is effective in reducing depressive symptoms.
- MBCT demonstrates a beneficial effect on suppressing inflammatory responses and optimizing cognitive functions, including attention and response to stimulation.
- The findings support the wide clinical implementation of MBCT as an adjunctive treatment for depression.
Objective:
This study was aimed to investigate the effectiveness of mindfulness-based cognitive therapy (MBCT) on depressive symptoms, brain potential, and neuroimmunoinflammatory factors in patients with depression.
Methods:
Sixty-four eligible patients according to the inclusion criteria were randomly divided into the control group and the observation group, with 32 patients in each group. The control group received conventional therapy, while the observation group received MBCT on top of conventional therapy. The depressive symptoms, brain potential, and neuroimmunoinflammatory factors were measured in the two groups.
Results:
After treatment, the Hamilton Depression Rating Scale score, tumor necrosis factor α, and interleukin-6 levels were decreased, while the World Health Organization Quality of Life Scale score, total number of response execution score, and 5-hydroxy tryptamine level were increased in both groups. Moreover, the Hamilton Depression Rating Scale score, tumor necrosis factor α, and interleukin-6 levels were decreased more significantly, while the World Health Organization Quality of Life Scale score, total number of response execution score, and 5-hydroxy tryptamine level were increased more significantly in the observation group compare to the control group ( P < 0.01). In addition, the latency in the observation group was shorter and the amplitude was longer than those in the control group ( P < 0.01).
Conclusions:
Compared with conventional therapy, the use of MBCT combined with conventional therapy can effectively reduce depressive symptoms, suppresses inflammatory responses, and optimize attention and response to target stimulation and is worthy of wide clinical implementation.
Related Concept Videos
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Cognitive Therapy
Depression: Overview
Stress Prevention and Stress Management Techniques III
The Role of Exercise in Stress Management
Regular physical activity is essential for reducing stress and promoting cardiovascular health. Exercise strengthens the heart, enhances blood flow, keeps blood vessels flexible, and helps lower blood pressure, all of which reduce the body's stress response. Research shows that adults who exercise regularly have nearly half the...

